GlassScriptPhysician profile
Gregory Armand Zollo
NPI 1023219573
$389.88
in general payments reported to CMS, 2019-2025
4 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $14.92 · 2023: $15.55 · 2024: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $109 · Food and Beverage: $33.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $109.48 |
| Food and Beverage | $33.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $341.53 | 2019-2024 | Opalescence |
| Solventum Corporation | $17.88 | 2024 | 3m Scotchbond, 3m Relyx, 3m Filtek |
| 3m Company | $15.55 | 2023 | Scotchbond Universal Plus, 3m Filtek, 3m Relyx |
| Philips North America LLC | $14.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Zollo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.